Jackson B, Franze L, Sumithran E, Johnston C
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia.
J Hypertens Suppl. 1988 Dec;6(4):S408-11. doi: 10.1097/00004872-198812040-00128.
Treatment with an angiotensin converting enzyme (ACE) inhibitor in renovascular hypertension produces acute effects on renal function; however, the long-term consequences of this are not known. We have studied the effect of chronic enalapril treatment on renal structure and function in the two-kidney, one clip model of renovascular hypertension in the rat. Four weeks after the left renal artery was clipped, the hypertensive rats were randomly allocated to treatment with enalapril, minoxidil or to no treatment. The drug dose was titrated for maximal hypotensive effect. After 4 months of treatment blood pressures were 129 +/- 3 mmHg (enalapril), 193 +/- 5 mmHg (minoxidil) and 220 +/- 4.8 mmHg (no treatment). Twelve months later survival was 84% (enalapril group), 48% (minoxidil group) and 15% (untreated group). Split kidney function (51Cr-EDTA clearance, ml/min) of the clipped kidneys was 0.0 (enalapril group), 0.26 +/- 0.23 (minoxidil group) and 0.74 +/- 0.13 (untreated group). The clipped kidney from enalapril-treated rats weighed 0.46 +/- 0.1 g, much less than in the minoxidil-treated group (1.2 +/- 0.07) or the untreated group (1.14 +/- 0.10). Enalapril treatment was withdrawn for 2 weeks in five rats, but the clipped kidney remained small and non-functional. Histological examination revealed marked interstitial fibrosis and tubular atrophy in clipped kidneys from both enalapril groups, in contrast to minor changes in the minoxidil-treated and the untreated groups. We conclude that chronic enalapril treatment of two-kidney, one clip hypertension in the rat improved survival and preserved total renal function, but was associated with irreversible fibrotic atrophy of the clipped kidney.
血管紧张素转换酶(ACE)抑制剂用于治疗肾血管性高血压会对肾功能产生急性影响;然而,其长期后果尚不清楚。我们研究了慢性依那普利治疗对大鼠肾血管性高血压双肾单夹模型的肾脏结构和功能的影响。左肾动脉夹闭四周后,将高血压大鼠随机分为依那普利组、米诺地尔组或不治疗组。调整药物剂量以达到最大降压效果。治疗4个月后,血压分别为129±3 mmHg(依那普利组)、193±5 mmHg(米诺地尔组)和220±4.8 mmHg(未治疗组)。十二个月后,生存率分别为84%(依那普利组)、48%(米诺地尔组)和15%(未治疗组)。夹闭肾的分肾功能(51Cr-EDTA清除率,ml/min)分别为0.0(依那普利组)、0.26±0.23(米诺地尔组)和0.74±0.13(未治疗组)。依那普利治疗组大鼠的夹闭肾重0.46±0.1 g,远低于米诺地尔治疗组(1.2±0.07)或未治疗组(1.14±0.10)。五只因那普利治疗的大鼠停药两周,但夹闭肾仍体积小且无功能。组织学检查显示,依那普利治疗组夹闭肾均有明显的间质纤维化和肾小管萎缩,而米诺地尔治疗组和未治疗组仅有轻微变化。我们得出结论,慢性依那普利治疗大鼠双肾单夹高血压可提高生存率并保留总肾功能,但与夹闭肾的不可逆纤维化萎缩有关。